Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

Affiliations

• ¹ Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
• ² Providence Cancer Center, Portland, Oregon, USA.
• ³ Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
• ⁴ Oncology, Georgetown University, Washington, DC, USA.
• ⁵ Comprehensive Cancer Center, University of Wisconsin System, Madison, Wisconsin, USA.
• ⁶ Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
• ⁷ Research, Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
• ⁸ Department of Microbiology and Immunology, University of California San Francisco, San Francisco, California, USA.
• ⁹ ESSA Pharma Inc, Redwood City, California, USA.
• ¹⁰ IGM Biosciences Inc, Mountain View, California, USA.
• ¹¹ Medical Oncology - Cancer Center Amsterdam, Amsterdam UMC - Locatie VUMC, Amsterdam, The Netherlands.
• ¹² AIVITA Biomedical, Inc, Irvine, California, USA.
• ¹³ Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA.
• ¹⁴ Medicine, UPMC Hillman Cancer Center, Pittsburgh, UK.
• ¹⁵ Pathology and Medicine, University of Chicago, Chicago, Illinois, USA.
• ¹⁶ NCI, National Institutes of Health, Bethesda, Maryland, USA.
• ¹⁷ Dana Farber Cancer Institute, Boston, Massachusetts, USA.
• ¹⁸ University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
• ¹⁹ Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA.
• ²⁰ Surgery, Immuneering Corp New York, New York, New York, USA.
• ²¹ University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
• ²² Medicine, University of Wisconsin Madison, Madison, Wisconsin, USA.
• ²³ Medical Oncology, City of Hope National Medical Center, Duarte, California, UK.
• ²⁴ Refuge Biotechnologies, Menlo Park, California, USA.
• ²⁵ Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.
• ²⁶ Massachusetts General Hospital Cancer Center, Harvard Medical Schoo, Massachusetts General Hospital, Boston, Massachusetts, USA.
• ²⁷ ESSA Pharma Inc, Palo Alto, California, USA.
• ²⁸ Oncology, University of Lausanne, Epalinges, VD, Switzerland.
• ²⁹ Pediatrics, University of Wisconsin Madison, Madison, Wisconsin, USA.
• ³⁰ Massachusetts Institute of Technology Koch Institute for Integrative Cancer Research, Cambridge, Massachusetts, USA.
• ³¹ Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
• ³² Interdisciplinary Program in Immunology, The University of Iowa, Iowa City, Iowa, USA.
• ³³ Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, Iowa, USA.
• ³⁴ Department of Internal Medicine, Division of General Medicine, The University of Iowa, Iowa City, Iowa, USA.
• ³⁵ MacroGenics Inc, Rockville, Maryland, USA.
• ³⁶ Laura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Medical Center, New York, New York, USA Jeffrey.Weber@nyulangone.org.